230 related articles for article (PubMed ID: 6145425)
21. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL
Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714
[TBL] [Abstract][Full Text] [Related]
22. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Leysen JE; Janssen PM; Megens AA; Schotte A
J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
[TBL] [Abstract][Full Text] [Related]
23. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
[TBL] [Abstract][Full Text] [Related]
24. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
25. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Neurochemical findings (author's transl)].
Bürki HR; Sayers AC; Ruch W; Asper H
Arzneimittelforschung; 1976; 26(6):1094-6. PubMed ID: 989385
[TBL] [Abstract][Full Text] [Related]
26. A comparison between some biochemical and behavioural effects produced by neuroleptics.
Fregnan GB; Porta R
Arzneimittelforschung; 1981; 31(1):70-4. PubMed ID: 6111328
[TBL] [Abstract][Full Text] [Related]
27. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
Marquis KL; Sabb AL; Logue SF; Brennan JA; Piesla MJ; Comery TA; Grauer SM; Ashby CR; Nguyen HQ; Dawson LA; Barrett JE; Stack G; Meltzer HY; Harrison BL; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2007 Jan; 320(1):486-96. PubMed ID: 17038512
[TBL] [Abstract][Full Text] [Related]
28. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
Matsubara R
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
[TBL] [Abstract][Full Text] [Related]
29. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment.
Racagni G; Bruno F; Bugatti A; Parenti M; Apud JA; Santini V; Carenzi A; Groppetti A; Cattabeni F
Adv Biochem Psychopharmacol; 1980; 24():45-51. PubMed ID: 7405672
[No Abstract] [Full Text] [Related]
30. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
31. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
32. A short survey on untoward effects of fluperlapine.
Müller-Oerlinghausen B
Arzneimittelforschung; 1984; 34(1A):131-4. PubMed ID: 6145429
[TBL] [Abstract][Full Text] [Related]
33. 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.
Howard HR; Lowe JA; Seeger TF; Seymour PA; Zorn SH; Maloney PR; Ewing FE; Newman ME; Schmidt AW; Furman JS; Robinson GL; Jackson E; Johnson C; Morrone J
J Med Chem; 1996 Jan; 39(1):143-8. PubMed ID: 8568801
[TBL] [Abstract][Full Text] [Related]
34. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.
Stanhope KJ; Mirza NR; Bickerdike MJ; Bright JL; Harrington NR; Hesselink MB; Kennett GA; Lightowler S; Sheardown MJ; Syed R; Upton RL; Wadsworth G; Weiss SM; Wyatt A
J Pharmacol Exp Ther; 2001 Nov; 299(2):782-92. PubMed ID: 11602695
[TBL] [Abstract][Full Text] [Related]
35. General pharmacology of clozapine.
Coward DM
Br J Psychiatry Suppl; 1992 May; (17):5-11. PubMed ID: 1358127
[TBL] [Abstract][Full Text] [Related]
36. Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine.
Cuomo V; Cagiano R; Mocchetti I; Coen E; Cattabeni F; Racagni G
Psychopharmacology (Berl); 1983; 81(3):239-43. PubMed ID: 6417713
[TBL] [Abstract][Full Text] [Related]
37. [Biochemical studies on tienocarbine and related compounds].
Schöllnhammer G; Seidel PR; Dell HD
Arzneimittelforschung; 1984; 34(10):1254-8. PubMed ID: 6083796
[TBL] [Abstract][Full Text] [Related]
38. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
Magnusson O; Fowler CJ; Köhler C; Ogren SO
Neuropharmacology; 1986 Feb; 25(2):187-97. PubMed ID: 2939362
[TBL] [Abstract][Full Text] [Related]
39. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
